Psychosocial repercussion of migraine: is it a stigmatized disease?

Martínez-Fernández, Alicia; Vega, Mónica Rueda; Quintas, Sonia; Heras, M de Toledo; Terán, Javier Díaz de; González, Germán Latorre; García, Olga Trabajos; Mora, José Vivancos; Gago-Veiga, Ana Beatriz

doi:10.1007/s10072-020-04332-6

Cited by 16 publications

(21 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

Section: Introductionmentioning

confidence: 99%

“…Stigma manifests as both prejudice of and rejection from society towards patients who suffer from a specific pathology [ 14 ]. A patient’s internalization of such discrimination can have repercussions on their state of mind and quality of life [ 14 ]. It is possible to distinguish between “enacted stigma”, which consists of actual discrimination and rejection by society towards the patient, and “internalized stigma”, whereby the patient becomes aware of the discrimination and internalizes the negative impact of their disease [ 15 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The stigma of patients with chronic insomnia: a clinical study

et al. 2022

BMC Psychiatry

View full text Add to dashboard Cite

Background The objective of this study was to explore the stigma and related influencing factors in individuals with chronic insomnia disorder (CID). Methods A total of 70 CID patients and 70 healthy controls (CON) were enrolled in the study. All subjects completed the assessments of sleep, emotion, and cognition. Their stigma and life quality were measured using the Chronic Stigma Scale and the 36-Item Short-Form Health Survey (SF-36). Results The ratio of individuals with stigma was significantly different between CID and CON groups (C2 = 35.6, p < 0.001). Compared with the CON group, the CID group had higher scores for total stigma (U = 662.0, p < 0.001), internalized stigma (U = 593.0, p < 0.001), enacted stigma (U = 1568.0, p < 0.001), PSQI (U = 2485.0, p < 0.001) and HAMD-17 (U = 69.5, p < 0.001) as well as lower scores for MoCA-C (U = 3997.5, p < 0.001) and most items of SF-36. Partial correlation analysis showed that different items of the Chronic Stigma Scale were positively correlated with illness duration, PSQI and HAMD-17 scores, while negatively correlated with one or more items of the SF-36. Multivariate regression analysis showed that illness duration and the Mental Health domain of the SF-36 were independent risk factors for one or more items of stigma in CID patients. Conclusion Patients with CID have an increased risk of stigma. Moreover, illness duration and Mental Health may be primary factors related to stigma.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The stigma of patients with chronic insomnia: a clinical study

et al. 2022

BMC Psychiatry

View full text Add to dashboard Cite

show abstract

“…Coincide esta visión con lo publicado por otros autores que hablan de rechazo o prejuicios de la sociedad hacia los pacientes con patologías crónicas como la migraña y afirman que existe un estigma en torno a la migraña, que parece ser más frecuente en pacientes con ciertas características sociodemográficas, y que relacionan con el estrés, las alteraciones del estado de ánimo y la baja autoestima. Intentar reducir estos factores podría contribuir a mejorar el control de la migraña y reducir el impacto de la enfermedad a nivel socioeconómico (28) .…”

Section: Discussionunclassified

Aspectos preventivos en migraña y trabajo. Encuesta europea

Herrero¹,

Torre²,

Barbero

et al. 2021

Arch Prev Riesgos Labor

View full text Add to dashboard Cite

Introducción: La promoción de la salud en el trabajo integra las iniciativas en salud y seguridad en ámbito ocupacional, con mejoras personales, incremento de productividad y menores riesgos y gastos sociales, especialmente en migraña, como enfermedad neurológica con prevalencia estimada en el 11% de la población. El objetivo de este trabajo fue conocer las condiciones preventivas de los trabajadores con migraña y las opciones de gestión preventiva en sus empresas. Método: Estudio observacional transversal realizado en 3.342 pacientes de España, Italia, Francia, Portugal, Irlanda, Reino Unido, Alemania y otros países de la UE mediante encuesta anónima en la web de la European Migraine & Headache Alliance (EMHA-web), entre septiembre de 2018 y enero de 2019. Resultados: Estrés laboral y uso de PVD son los riesgos más referidos por los trabajadores con migraña. El 43.71% de trabajadores desconoce el tipo de Servicio de Prevención de su empresa, 49.06% no dispone de servicio médico; el 67.67% no ha tenido impedimentos de acceso laboral por migraña, ni despido o no renovación del contrato, pero el 42,14% tuvo algún conflicto por pérdida de productividad; el 26,54% desconoce el concepto de especial sensibilidad o no lo ha solicitado por migraña; un 55,42% no se ha sentido comprendido ni apoyado por su empresa en sus limitaciones por migraña, pero sí por los compañeros. Conclusión: Se observa una deficiente información preventiva y escaso uso de las opciones de gestión adaptativa en las empresas para personas con migraña.

show abstract

“…Aura symptoms are fully reversible and they can be visual, sensory, speech, motor, brainstem and retinal [1]. Numerous epidemiological studies report widespread prevalence of migraine and its burdensome health effects and socio-economic costs [2][3][4].…”

Section: Introductionmentioning

confidence: 99%

Prenatal oestrogen-testosterone balance as a risk factor of migraine in adults

et al. 2021

View full text Add to dashboard Cite

Background Migraine is a common neurological disease with extremely debilitating, but fully reversible symptoms. Women suffer from migraine more often than men. It was assumed that fluctuation of oestrogen level during menstrual cycle is one of many factors responsible for more frequent migraine attacks. The second-to-fourth digit ratio (2D:4D) is considered as an indicator of prenatal sex steroids. Balance of prenatal androgens (testosterone) and oestrogen has been studied in numerous diseases that are affected by hormones. However, the relationship between migraine and the sex steroids balance in prenatal development is still unexplained. The aim of this paper is to provide an evidence of relationship between prenatal oestrogen and testosterone exposure following 2D:4D digit ratio, and migraine prevalence in adults. Methods We examined a group of 151 adults (33 males, 118 females) with migraine and a control group of 111 adults (45 males, 66 females). 2D:4D digit ratio of both hands was measured using sliding Vernier calliper. Results Significant differences were found in the right hand. Female migraineurs had lower value of 2D:4D ratio than the control group and the right 2D:4D was lower than left 2D:4D (Δ2D:4D), suggesting prenatal testosterone dominance. The opposite relationship was observed in males. Male migraineurs had higher value of 2D:4D ratio and Δ2D:4D was greater than the control group, suggesting prenatal oestrogen dominance. Conclusions Our results suggest that depending on sex, different proportion of prenatal sex steroids might be a risk factor of migraine in adults. Women with migraine were presumably exposed in prenatal life to higher testosterone levels relative to oestrogen, while men with migraine were probably exposed in prenatal life to higher levels of oestrogen relative to testosterone.

show abstract

Psychosocial repercussion of migraine: is it a stigmatized disease?

Cited by 16 publications

References 23 publications

The stigma of patients with chronic insomnia: a clinical study

The stigma of patients with chronic insomnia: a clinical study

Aspectos preventivos en migraña y trabajo. Encuesta europea

Prenatal oestrogen-testosterone balance as a risk factor of migraine in adults

Contact Info

Product

Resources

About